vs
Orthofix Medical Inc.（OFIX）与PEGASYSTEMS INC（PEGA）财务数据对比。点击上方公司名可切换其他公司
PEGASYSTEMS INC的季度营收约是Orthofix Medical Inc.的2.0倍（$430.0M vs $219.9M），PEGASYSTEMS INC净利率更高（7.6% vs -1.0%，领先8.6%），Orthofix Medical Inc.同比增速更快（2.0% vs -9.6%），PEGASYSTEMS INC自由现金流更多（$206.5M vs $16.8M），过去两年PEGASYSTEMS INC的营收复合增速更高（10.7% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Pegasystems Inc.（简称Pega）是1983年成立的全球软件企业，总部位于美国马萨诸塞州沃尔瑟姆，1996年于纳斯达克上市，股票代码PEGA。公司主打低代码平台，面向企业客户提供工作流自动化、生成式AI驱动决策等相关解决方案。
OFIX vs PEGA — 直观对比
营收规模更大
PEGA
是对方的2.0倍
$219.9M
营收增速更快
OFIX
高出11.6%
-9.6%
净利率更高
PEGA
高出8.6%
-1.0%
自由现金流更多
PEGA
多$189.7M
$16.8M
两年增速更快
PEGA
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $430.0M |
| 净利润 | $-2.2M | $32.8M |
| 毛利率 | 71.1% | 75.2% |
| 营业利润率 | 0.2% | 8.6% |
| 净利率 | -1.0% | 7.6% |
| 营收同比 | 2.0% | -9.6% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPEGA
| Q1 26 | — | $430.0M | ||
| Q4 25 | $219.9M | $504.3M | ||
| Q3 25 | $205.6M | $381.4M | ||
| Q2 25 | $203.1M | $384.5M | ||
| Q1 25 | $193.6M | $475.6M | ||
| Q4 24 | $215.7M | $490.8M | ||
| Q3 24 | $196.6M | $325.1M | ||
| Q2 24 | $198.6M | $351.2M |
净利润OFIXPEGA
| Q1 26 | — | $32.8M | ||
| Q4 25 | $-2.2M | $234.6M | ||
| Q3 25 | $-22.8M | $43.4M | ||
| Q2 25 | $-14.1M | $30.1M | ||
| Q1 25 | $-53.1M | $85.4M | ||
| Q4 24 | $-29.1M | $119.1M | ||
| Q3 24 | $-27.4M | $-14.4M | ||
| Q2 24 | $-33.4M | $6.6M |
毛利率OFIXPEGA
| Q1 26 | — | 75.2% | ||
| Q4 25 | 71.1% | 79.5% | ||
| Q3 25 | 72.2% | 72.2% | ||
| Q2 25 | 68.7% | 71.5% | ||
| Q1 25 | 62.8% | 78.5% | ||
| Q4 24 | 69.0% | 79.1% | ||
| Q3 24 | 68.7% | 70.2% | ||
| Q2 24 | 67.8% | 72.4% |
营业利润率OFIXPEGA
| Q1 26 | — | 8.6% | ||
| Q4 25 | 0.2% | 20.7% | ||
| Q3 25 | -8.3% | 3.8% | ||
| Q2 25 | -7.9% | 4.5% | ||
| Q1 25 | -25.2% | 26.7% | ||
| Q4 24 | -5.3% | 29.1% | ||
| Q3 24 | -9.6% | -3.6% | ||
| Q2 24 | -12.5% | 3.7% |
净利率OFIXPEGA
| Q1 26 | — | 7.6% | ||
| Q4 25 | -1.0% | 46.5% | ||
| Q3 25 | -11.1% | 11.4% | ||
| Q2 25 | -6.9% | 7.8% | ||
| Q1 25 | -27.4% | 18.0% | ||
| Q4 24 | -13.5% | 24.3% | ||
| Q3 24 | -13.9% | -4.4% | ||
| Q2 24 | -16.8% | 1.9% |
每股收益（稀释后）OFIXPEGA
| Q1 26 | — | $0.18 | ||
| Q4 25 | $-0.05 | $0.81 | ||
| Q3 25 | $-0.57 | $0.24 | ||
| Q2 25 | $-0.36 | $0.17 | ||
| Q1 25 | $-1.35 | $0.91 | ||
| Q4 24 | $-0.76 | $1.35 | ||
| Q3 24 | $-0.71 | $-0.17 | ||
| Q2 24 | $-0.88 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $270.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $705.9M |
| 总资产 | $850.6M | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXPEGA
| Q1 26 | — | $270.0M | ||
| Q4 25 | $82.0M | $425.8M | ||
| Q3 25 | $62.9M | $351.4M | ||
| Q2 25 | $65.6M | $411.6M | ||
| Q1 25 | $58.0M | $371.7M | ||
| Q4 24 | $83.2M | $740.0M | ||
| Q3 24 | $30.1M | $703.0M | ||
| Q2 24 | $26.4M | $665.1M |
总债务OFIXPEGA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — |
股东权益OFIXPEGA
| Q1 26 | — | $705.9M | ||
| Q4 25 | $450.0M | $787.4M | ||
| Q3 25 | $442.5M | $596.8M | ||
| Q2 25 | $458.3M | $624.5M | ||
| Q1 25 | $458.3M | $611.3M | ||
| Q4 24 | $503.1M | $585.5M | ||
| Q3 24 | $525.9M | $473.0M | ||
| Q2 24 | $546.0M | $435.4M |
总资产OFIXPEGA
| Q1 26 | — | $1.6B | ||
| Q4 25 | $850.6M | $1.6B | ||
| Q3 25 | $832.6M | $1.3B | ||
| Q2 25 | $837.2M | $1.3B | ||
| Q1 25 | $823.1M | $1.3B | ||
| Q4 24 | $893.3M | $1.8B | ||
| Q3 24 | $867.9M | $1.6B | ||
| Q2 24 | $882.0M | $1.5B |
负债/权益比OFIXPEGA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | — |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $206.5M |
| 自由现金流率自由现金流/营收 | 7.6% | 48.0% |
| 资本支出强度资本支出/营收 | 4.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $494.9M |
8季度趋势，按日历期对齐
经营现金流OFIXPEGA
| Q1 26 | — | — | ||
| Q4 25 | $27.7M | $158.4M | ||
| Q3 25 | $12.4M | $56.3M | ||
| Q2 25 | $11.6M | $86.3M | ||
| Q1 25 | $-18.4M | $204.2M | ||
| Q4 24 | $23.7M | $95.2M | ||
| Q3 24 | $11.7M | $30.5M | ||
| Q2 24 | $9.0M | $40.1M |
自由现金流OFIXPEGA
| Q1 26 | — | $206.5M | ||
| Q4 25 | $16.8M | $152.4M | ||
| Q3 25 | $2.5M | $51.8M | ||
| Q2 25 | $4.5M | $84.1M | ||
| Q1 25 | $-25.1M | $202.3M | ||
| Q4 24 | $15.2M | $92.4M | ||
| Q3 24 | $6.3M | $27.4M | ||
| Q2 24 | $-360.0K | $38.8M |
自由现金流率OFIXPEGA
| Q1 26 | — | 48.0% | ||
| Q4 25 | 7.6% | 30.2% | ||
| Q3 25 | 1.2% | 13.6% | ||
| Q2 25 | 2.2% | 21.9% | ||
| Q1 25 | -13.0% | 42.5% | ||
| Q4 24 | 7.0% | 18.8% | ||
| Q3 24 | 3.2% | 8.4% | ||
| Q2 24 | -0.2% | 11.1% |
资本支出强度OFIXPEGA
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 1.2% | ||
| Q3 25 | 4.8% | 1.2% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 3.5% | 0.4% | ||
| Q4 24 | 4.0% | 0.6% | ||
| Q3 24 | 2.7% | 0.9% | ||
| Q2 24 | 4.7% | 0.4% |
现金转化率OFIXPEGA
| Q1 26 | — | — | ||
| Q4 25 | — | 0.68× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 2.87× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 0.80× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PEGA
| Pega Cloud | $205.0M | 48% |
| Subscription license | $94.9M | 22% |
| Maintenance | $75.3M | 18% |
| Consulting | $54.8M | 13% |
